Thursday, May 05, 2022 2:25:11 AM
Hank,
Trial results are commonly presented at conference, like ASCO, with similar or more restrictive access. I do believe that TLD will be issued prior to the technical presentation, but Dr. Liau's presentation will be considered as peer reviewed, so after it the company can discuss it, and it can be posted on their website, it's no different than other similar conferences IMHO. I don't know that the Journal is going to be available for free either, I don't believe it is. Once out once again I believe the company may be able to put it on their website, they certainly will be able to discuss it.
I do believe that the TLD statement should be out prior to Dr. Liau's presentation, but it might be done with a release the morning of the presentation, the same may be true of an update of Clinical Trials. The company knows what it's doing, this is well planned and whether the Journal is out prior to ASCO or not the company will be positioned to discuss what's been presented at the Experts Theater. Frankly I'm uncertain if they can webcast directly from the Experts Theater, or if that has to wait, it would be governed by ASCO rules.
Only the presentation on Tuesday has been formally announced by the company, releases should come out for TLD, for the presentation at the Expert Theater, and for the Annual Meeting in the next couple weeks in addition to first quarter results which I believe is due by the 15th, that's a lot of news after over a year and a half of quiet.
Gary
Trial results are commonly presented at conference, like ASCO, with similar or more restrictive access. I do believe that TLD will be issued prior to the technical presentation, but Dr. Liau's presentation will be considered as peer reviewed, so after it the company can discuss it, and it can be posted on their website, it's no different than other similar conferences IMHO. I don't know that the Journal is going to be available for free either, I don't believe it is. Once out once again I believe the company may be able to put it on their website, they certainly will be able to discuss it.
I do believe that the TLD statement should be out prior to Dr. Liau's presentation, but it might be done with a release the morning of the presentation, the same may be true of an update of Clinical Trials. The company knows what it's doing, this is well planned and whether the Journal is out prior to ASCO or not the company will be positioned to discuss what's been presented at the Experts Theater. Frankly I'm uncertain if they can webcast directly from the Experts Theater, or if that has to wait, it would be governed by ASCO rules.
Only the presentation on Tuesday has been formally announced by the company, releases should come out for TLD, for the presentation at the Expert Theater, and for the Annual Meeting in the next couple weeks in addition to first quarter results which I believe is due by the 15th, that's a lot of news after over a year and a half of quiet.
Gary
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
